Skip to main content
Year archive

ADHERIUM LIMITED — 2024 filings

All 73 regulatory filings released by ADHERIUM LIMITED (ADR) in 2024, sourced directly from the official regulator.

73 Filings
2024 Period
2024 filings (73)
Filing Released Lang
Notification regarding unquoted securities - ADR 6 pages 18.9KB
Share Issue/Capital Change
2024-12-08 English
Adherium, AMC Health partner for Improved Respiratory Care 2 pages 123.9KB
Regulatory Filings
2024-12-04 English
Partnership with Tenovi for Remote Patient Monitoring 2 pages 143.9KB
Regulatory Filings
2024-12-03 English
Adherium Secures R&D Loan Facility 2 pages 95.0KB
Capital/Financing Update
2024-12-03 English
Results of Meeting 2 pages 120.4KB
Declaration of Voting Results & Voting Rights Announcements
2024-11-14 English
Amended Constitution 54 pages 841.4KB
Governance Information
2024-11-14 English
Quarterly Activities/Appendix 4C Cash Flow Report 9 pages 1.2MB
Interim / Quarterly Report
2024-10-30 English
Management Change 1 page 173.0KB
Board/Management Information
2024-10-29 English
Notice of Annual General Meeting/Proxy Form - Replacement 18 pages 653.8KB
AGM Information
2024-10-08 English
Notice of Annual General Meeting/Proxy Form 15 pages 622.8KB
AGM Information
2024-10-07 English
Appendix 4G & Corporate Governance Statement 26 pages 672.2KB
Regulatory Filings
2024-09-29 English
Annual Report to shareholders 64 pages 20.3MB
Annual Report
2024-09-29 English
Update - Notification of cessation of securities - ADR 4 pages 14.8KB
Regulatory Filings
2024-08-29 English
Preliminary Final Report 12 pages 1.7MB
Annual Report
2024-08-28 English
Quarterly Activities/Appendix 4C Cash Flow Report 9 pages 1.2MB
Interim / Quarterly Report
2024-07-29 English
Ceasing to be a substantial holder 8 pages 161.2KB
Major Shareholding Notification
2024-07-24 English
Notification of cessation of securities - ADR 4 pages 15.0KB
Share Issue/Capital Change
2024-07-09 English
Change of Director's Interest Notice - L Panaccio 2 pages 216.6KB
Director's Dealing
2024-07-02 English
Change of Director's Interest Notice - G Baran 3 pages 221.8KB
Director's Dealing
2024-07-02 English
Becoming a substantial holder 8 pages 237.2KB
Major Shareholding Notification
2024-07-01 English
Notification regarding unquoted securities - ADR 5 pages 16.9KB
Share Issue/Capital Change
2024-06-30 English
Notification regarding unquoted securities - ADR 5 pages 16.7KB
Share Issue/Capital Change
2024-06-30 English
Application for quotation of securities - ADR 6 pages 18.2KB
Share Issue/Capital Change
2024-06-30 English
Results of Extraordinary General Meeting 2 pages 174.1KB
Declaration of Voting Results & Voting Rights Announcements
2024-06-20 English
Adherium secures a strategic partnership with VRI 3 pages 127.0KB
Regulatory Filings
2024-06-17 English
Change in substantial holding - Updated 2 pages 296.3KB
Major Shareholding Notification
2024-06-04 English
Change in substantial holding 2 pages 296.4KB
Major Shareholding Notification
2024-06-03 English
Change of Director's Interest Notice - B McHarrie 2 pages 268.0KB
Director's Dealing
2024-06-02 English
Change of Director's Interest Notice - G Baran 3 pages 274.8KB
Director's Dealing
2024-06-02 English
Change of Director's Interest Notice - L Panaccio 2 pages 231.7KB
Director's Dealing
2024-06-02 English
Change in substantial holding 4 pages 593.9KB
Major Shareholding Notification
2024-05-29 English
Change in substantial holding 2 pages 216.7KB
Major Shareholding Notification
2024-05-28 English
Change in substantial holding 2 pages 639.7KB
Major Shareholding Notification
2024-05-28 English
Becoming a substantial holder 4 pages 771.8KB
Major Shareholding Notification
2024-05-27 English
Notification regarding unquoted securities - ADR 5 pages 16.9KB
Share Issue/Capital Change
2024-05-26 English
Application for quotation of securities - ADR 6 pages 18.1KB
Share Issue/Capital Change
2024-05-26 English
AstraZeneca selected Adherium Smartinhaler for its study 2 pages 122.0KB
Capital/Financing Update
2024-05-23 English
Non-Renounceable Rights Issue Offer Completes 2 pages 124.8KB
Capital/Financing Update
2024-05-22 English
Notice of Extraordinary General Meeting/Proxy Form 27 pages 10.5MB
Proxy Solicitation & Information Statement
2024-05-22 English
Change of Company Secretary 2 pages 89.1KB
Board/Management Information
2024-05-19 English
Ceasing to be a substantial holder 8 pages 226.8KB
Major Shareholding Notification
2024-05-15 English
Attending American Thoracic Society International Conference 2 pages 88.4KB
Regulatory Filings
2024-05-14 English
Change in substantial holding 2 pages 307.5KB
Major Shareholding Notification
2024-05-12 English
Disclosure of Long Equity Derivative Positions 2 pages 148.2KB
Major Shareholding Notification
2024-05-09 English
Becoming a substantial holder 8 pages 425.9KB
Major Shareholding Notification
2024-05-07 English
Change in substantial holding 3 pages 93.8KB
Major Shareholding Notification
2024-05-06 English
Entitlement Offer Opens and Letters to Shareholders 6 pages 217.9KB
Capital/Financing Update
2024-05-05 English
Application for quotation of securities - ADR 6 pages 18.7KB
Capital/Financing Update
2024-05-02 English
Ceasing to be a substantial holder 9 pages 163.2KB
Major Shareholding Notification
2024-04-30 English
Quarterly Activities/Appendix 4C Cash Flow Report 10 pages 487.5KB
Interim / Quarterly Report
2024-04-28 English
Placement and Entitlement Offer to raise up to $8.37 million 5 pages 215.9KB
Capital/Financing Update
2024-04-25 English
Proposed issue of securities - ADR 14 pages 46.2KB
Capital/Financing Update
2024-04-25 English
Investor Presentation 28 pages 3.9MB
Investor Presentation
2024-04-25 English
Prospectus 51 pages 719.5KB
Capital/Financing Update
2024-04-25 English
Trading Halt 2 pages 156.0KB
Capital/Financing Update
2024-04-22 English
Disclosure of Long Equity Derivative Positions 2 pages 206.3KB
Major Shareholding Notification
2024-04-17 English
Application for quotation of securities - ADR 7 pages 20.8KB
Share Issue/Capital Change
2024-04-16 English
Notification regarding unquoted securities - ADR 6 pages 19.1KB
Share Issue/Capital Change
2024-04-16 English
US FDA clearance of Hailie for AstraZeneca inhalers 2 pages 144.1KB
Regulatory Filings
2024-04-14 English
Change of Director Interest Notices x 2 - Expiry of Options 4 pages 322.1KB
Director's Dealing
2024-04-03 English
Rimidi Partnership for Respiratory Clinical Management 4 pages 133.5KB
Regulatory Filings
2024-04-02 English
Notification of cessation of securities - ADR 4 pages 14.8KB
Share Issue/Capital Change
2024-04-01 English
Change in substantial holding 8 pages 230.3KB
Major Shareholding Notification
2024-03-26 English
First Patient Enrolled in Major e-health Clinical Study 3 pages 153.1KB
Regulatory Filings
2024-03-19 English
Adherium receives $1.5m Australian R&D Tax Rebate 1
Capital/Financing Update
2024-03-06 English
Half Yearly Report and Accounts 22 pages 6.3MB
Interim / Quarterly Report
2024-02-28 English
Alliance Tech Medical Partnership to expand US product reach 3 pages 147.3KB
Regulatory Filings
2024-02-28 English
Adherium Exhibiting at AAAAI 2024 Annual Meeting 2 pages 141.9KB
Regulatory Filings
2024-02-21 English
New CEO Appointed - Dr Paul Mastoridis 2 pages 162.2KB
Board/Management Information
2024-01-31 English
Quarterly Activities/Appendix 4C Cash Flow Report 9 pages 398.1KB
Interim / Quarterly Report
2024-01-30 English
Resignation of CEO 2 pages 110.4KB
Board/Management Information
2024-01-15 English
Partnership with NuvoAir Medical to Enhance Patient Outcomes 2 pages 112.0KB
Regulatory Filings
2024-01-09 English
Change of Company Address 1 page 104.4KB
Regulatory Filings
2024-01-09 English